person

Hedwig D.

Country
Germany
Department
Päd Onkologie Hämatologie

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
102
Sites with multiple studies

Has run more than one trial at 102 of 213 partner sites.

Specializations

Pediatric Oncology

The investigator specializes in treating severe forms of childhood cancers, with particular emphasis on neuroblastoma and acute lymphoblastic leukemia. Their expertise centers on developing innovative therapeutic approaches for high-risk pediatric cancer patients.

  • High-risk neuroblastoma management
  • Advanced leukemia treatment protocols
  • Pediatric cancer therapeutics

Their work encompasses comprehensive treatment strategies for newly diagnosed pediatric cancer cases.

Immunotherapy

The investigator focuses on implementing immunotherapeutic approaches in pediatric cancer treatment, particularly exploring the integration of dinutuximab beta with established treatment protocols. Their work involves developing combination therapy strategies.

  • Antibody-based treatments
  • Combination therapy approaches
  • Immunological response in cancer

Their expertise includes evaluating novel immunotherapy combinations for optimal treatment outcomes.

Stem Cell Transplantation

The investigator specializes in allogeneic stem cell transplantation procedures, focusing on various conditioning regimens and donor matching strategies. Their work encompasses both traditional and innovative transplantation approaches.

  • Conditioning protocols
  • HLA matching strategies
  • Post-transplant care

Their research includes evaluating different donor types and conditioning methods for optimal transplant outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.